Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
about
The role of lipoxin A4 in endometrial biology and endometriosisInternational Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) familySelective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1Insulin-Sensitizing Effects of Omega-3 Fatty Acids: Lost in Translation?Key mechanisms governing resolution of lung inflammationω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary RelevanceWound repair: role of immune-epithelial interactionsResolution of inflammation in asthmaEicosanoid profiling in colon cancer: emergence of a patternLinks demystified: Periodontitis and cancerThe cannabinoid acids, analogs and endogenous counterpartsCurrent evidence linking polyunsaturated Fatty acids with cancer risk and progressionHIF1A reduces acute lung injury by optimizing carbohydrate metabolism in the alveolar epitheliumLow doses of imatinib induce myelopoiesis and enhance host anti-microbial immunity5-Lipoxygenase pathway in experimental abdominal aortic aneurysmsThe Immune System in Tissue Environments Regaining Homeostasis after Injury: Is "Inflammation" Always Inflammation?Role of Antioxidants and Natural Products in InflammationNociceptin system as a target in sepsis?Roles of resolvins in the resolution of acute inflammationThrombin and vascular inflammationLipid mediators in the resolution of inflammationThe specialized proresolving mediator 17-HDHA enhances the antibody-mediated immune response against influenza virus: a new class of adjuvant?Effects of gut-targeted 15-LOX-1 transgene expression on colonic tumorigenesis in miceFunctional Metabolomics Reveals Novel Active Products in the DHA MetabolomeSpecialized proresolving mediators (SPMs) inhibit human B-cell IgE productionDHA- and EPA-derived resolvins, protectins, and maresins in airway inflammationResolvin D1 binds human phagocytes with evidence for proresolving receptorsUpdate on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7Effect of Different Omega-6/Omega-3 Polyunsaturated Fatty Acid Ratios on the Formation of Monohydroxylated Fatty Acids in THP-1 Derived MacrophagesProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeMaresin 1 mitigates LPS-induced acute lung injury in miceQuantitative profiling method for oxylipin metabolome by liquid chromatography electrospray ionization tandem mass spectrometryCandida albicans modulates host defense by biosynthesizing the pro-resolving mediator resolvin E1In vitro and in vivo anti-inflammatory activity of 17-O-acetylacuminolide through the inhibition of cytokines, NF-κB translocation and IKKβ activityA metabolomic analysis of two intravenous lipid emulsions in a murine modelResolution of acute inflammation in the lungImpaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1Maresin 1 induces a novel pro-resolving phenotype in human plateletsD-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization.Localized delivery of low-density lipoprotein docosahexaenoic acid nanoparticles to the rat brain using focused ultrasound
P2860
Q24564121-74684BED-9599-4EC7-B2AD-AC6F22674C91Q24652940-9C0723F7-D19C-4500-90A1-2D5C1B9D70BBQ24658245-111C9F13-3FDF-4164-8B59-A7B187F8A7E5Q26748802-FF98C748-6DB2-4D37-BF0A-161A1CE683CDQ26749606-441AED3C-E1A6-49D6-9B8B-A5E06B498E3CQ26782277-AC99AFB3-71BF-4AD3-97A7-97D155A986F2Q26801818-8F93130A-76DA-48C3-AB27-81D3D5E12DF5Q26823724-BE5A05CF-3B46-4E3B-94FD-57BA576D68C5Q26859889-FCDFFDDF-D31F-4BF5-BF48-1007A2C6126DQ26865599-F6059DA3-FA7C-4552-B4A3-AB5C782285C1Q27009735-40D15E3E-ED0A-48FD-BD2E-F85064BB025CQ27022573-E008E3FF-AF65-482E-9D2A-3CCDDFE73C79Q27316863-68280A8D-B50A-45AC-AC4E-58AE2743C9F1Q27320733-9675F57A-D7B4-4AC9-AD7E-16F592DA0822Q27342659-390EDD8F-9458-4A7F-80C2-B52C3ED057ECQ28066426-A4528807-A02E-4426-B312-92EB0E87B1CCQ28079468-3FBD3455-5053-4430-BFB1-3DE520A915C7Q28238087-2402402B-F5D3-4F7D-97E3-92156361D553Q28244502-8910D768-DDDD-4010-BAA8-BF3D233A234CQ28246124-5CC0BEB1-7948-4DE3-BEA0-3FCA0C5BB2CDQ28250668-F62B9199-A398-4CDA-8DF5-D92AA7B45102Q28251512-7FF0B88E-2EC0-4D32-B14E-5DA5A5842412Q28263562-A2B10BE0-B699-4ACE-B7D8-774DDE9843E4Q28266178-A2F154BC-6A5D-4B9F-B493-CDEB90E7221FQ28268731-EA5E6D21-862C-4724-BF8C-0D6826ECF2F6Q28269550-5B4ECB62-991A-4CB5-A631-D0CD1F484183Q28270638-E7441EFD-F034-4172-BF66-1EE3114994CAQ28308192-D3FD7F0A-AF7C-4D8B-9089-87ED6032C5ECQ28383078-E860FD0B-71D3-4ECA-B3E4-714F65F1F083Q28387661-8D9789AA-7D6A-43F3-9923-5CDB5DE07576Q28390696-9781005B-B157-4B0A-8866-24096B824567Q28397076-4B32BEDD-2243-4664-A02A-52235BAD577EQ28471781-12CF040D-4294-4ECC-B590-F69C01C85449Q28476407-7781F9F8-5FD6-4500-ABE9-B2ADDB24A2DDQ28485918-4579068C-D533-4496-B20C-632C5CB9E9BDQ28652204-854B6193-01F8-4746-9254-312F8E680B37Q28740401-BCB3F431-3CEF-455E-8F69-9BEE077923B0Q29248094-002EF34D-D4F3-40E0-9ABD-78952D1333AAQ30275955-7754367D-7AD8-4D75-9FD6-35C539F9CC87Q30362081-D8228287-868A-40BA-814F-85B50F690910
P2860
Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Resolution phase of inflammati ...... lipid mediators and pathways.
@ast
Resolution phase of inflammati ...... lipid mediators and pathways.
@en
type
label
Resolution phase of inflammati ...... lipid mediators and pathways.
@ast
Resolution phase of inflammati ...... lipid mediators and pathways.
@en
prefLabel
Resolution phase of inflammati ...... lipid mediators and pathways.
@ast
Resolution phase of inflammati ...... lipid mediators and pathways.
@en
P1476
Resolution phase of inflammati ...... lipid mediators and pathways.
@en
P2093
Charles N Serhan
P304
P356
10.1146/ANNUREV.IMMUNOL.25.022106.141647
P577
2007-01-01T00:00:00Z